Schizophrenia Drugs Market Is Slated To Witness Tremendous Growth In Future
Schizophrenia Drugs Industry The global schizophrenia drugs market is projected to reach USD 11.20 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Several factors are expected to drive the growth of the market, including advancements in drug delivery technologies, the increasing availability of Long-Acting Injectables (LAIs), and a rising number of patients seeking treatment. Key features that are expected to drive the adoption of novel schizophrenia drugs include a fast onset of action, improved accessibility for patients, high efficiency, and enhanced patient compliance, which are likely to facilitate market penetration. Schizophrenia remains a significant burden on patients, their families, and society at large, both from a health and socioeconomic perspective. As awareness of mental health issues, particularly schizophrenia, continues to increase among patients and healthcare pr...